Gardasil- A Case of Insufficient Testing?
Despite no recorded outbreak of cervical cancer nor change in sexual behavioral risks among teenagers, Gardasil vaccine was studied for less than two years prior to its approval. This was particularly curious since the cancer the vaccine purports to prevent does not present itself for 20-30 years.
And, while the drug was tested only on women aged 16-23 before it became the first licensed HPV vaccine in the United States, today it is recommended for boys and girls as young as 10 years old.
Moreover, Gardasil was not tested on people with health problems nor in combination with all the other vaccines routinely administered to American adolescents, such as Tdap and meningococcal vaccines.